Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Vaccine Development and Evaluation Centre

- PMLiVE

UK government and NIHR accelerate plans to improve clinical research delivery

The government has created a focused plan for action to transform UK clinical research

- PMLiVE

UK’s Autumn Budget details measures to boost life sciences sector

The new budget will aim to advance research and manufacturing in the UK

- PMLiVE

Landmark UK medicines deal to save NHS £14bn in medicine costs

The agreement will help provide lifesaving treatments and care for NHS patients

- PMLiVE

UKHSA secures UK-based vaccine deal for future influenza pandemics

CSL Sequiris will be ready to produce over 100 million influenza pandemic vaccines

- PMLiVE

UK rejoins Horizon Europe research initiative under new bespoke agreement

The UK will now participate as a fully associated member for the rest of the programme

- PMLiVE

Alzheimer’s Research UK calls on party leaders to tackle dementia pressures

One in three people living with dementia in England never receive a formal diagnosis

- PMLiVE

NHS expands diagnostic capabilities to reform cancer standards for patients

Thousands of patients are set to receive faster diagnosis and treatment

- PMLiVE

UK government invests £210m to fight antimicrobial resistance

The investment is the largest by a single country in global AMR surveillance

- PMLiVE

UK government allocates £250m for more NHS hospital beds in England

The funds will provide another 5,000 beds this winter to relieve pressure on hospitals and cut waiting times

- PMLiVE

UK government unveils vaccine development hub to strengthen pandemic defences

The centre will support the development of vaccines against new threats

- PMLiVE

UKHSA data reveals a 45% decline in hepatitis C prevalence in England

More than 80,000 people have been treated for the virus by NHS England since 2015

- PMLiVE

UK experts and politicians meet to discuss challenges faced by progressive MS patients

Primary-progressive MS accounts for approximately 10-15% of multiple sclerosis cases

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links